Digital Repository

Melioidosis with a subdural collection - a case report.

Show simple item record

dc.contributor.author Amarasena, H. L. P.
dc.contributor.author Silva, F. H. D. S.
dc.contributor.author Tilakaratna, P. M. Y. I.
dc.contributor.author Jayamanne, S. F.
dc.contributor.author Ranawaka, U. K.
dc.date.accessioned 2019-02-21T06:52:29Z
dc.date.available 2019-02-21T06:52:29Z
dc.date.issued 2019
dc.identifier.citation BMC infectious diseases.2019; 19(1):143 en_US
dc.identifier.issn 1471-2334 (Electronic)
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/19971
dc.description Indexed in MEDLINE en_US
dc.description.abstract BACKGROUND:Melioidosis is an infection caused by Burkholderia pseudomallei, which is more prevalent in the tropics and leads to significant morbidity and mortality. It characteristically produces widespread caseous lesions and abscesses, and can present with varied clinical manifestations. Melioidosis involving the central nervous system is uncommon. CASE PRESENTATION: A 42-year-old Sri Lankan male with type 2 diabetes presented with a febrile illness of 6 days with headache and constitutional symptoms. Clinical examination was unremarkable. Four days later, he developed focal seizures involving the left leg and numbness of the left side. Initial laboratory investigations were suggestive of a bacterial infection. Blood culture was reported as positive for a Pseudomonas species, which was resistant to gentamicin. Contrast enhanced CT and MRI scans of the brain showed a subdural collection in the right fronto-temporo-parietal region with possible abscess formation. Melioidosis antibody testing using indirect hemagglutination method was reactive with a titre more than 1/10,240. He was treated with intravenous meropenem and oral co-trimoxazole for 8 weeks (Intensive phase). The subdural collection was managed conservatively, and seizures were treated with oral antiepileptics. At 7 weeks, follow-up contrast enhanced MRI showed improvement of the subdural collection, and inflammatory markers had normalized. He was discharged after 8 weeks, and treated with oral co-trimoxazole and doxycycline for 6 months (eradication phase). At 6 months follow-up, the patient is asymptomatic. CONCLUSIONS: Cerebral melioidosis is an unusual presentation of melioidosis where the diagnosis can be easily missed. Knowledge of the protean manifestations of melioidosis is of paramount importance in order to detect and treat this potentially fatal infection appropriately, especially in tropical countries where the disease is endemic. en_US
dc.language.iso en en_US
dc.publisher BioMed Central,London en_US
dc.subject Melioidosis en_US
dc.title Melioidosis with a subdural collection - a case report. en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Advanced Search

Browse

My Account